Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 18, 1999 | Published
Journal Article Open

Bivalent Inhibitor of the N-end Rule Pathway

Abstract

The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. Ubr1p, the recognition (E3) component of the Saccharomyces cerevisiae N-end rule pathway, contains at least two substrate-binding sites. The type 1 site is specific for N-terminal basic residues Arg, Lys, and His. The type 2 site is specific for N-terminal bulky hydrophobic residues Phe, Leu, Trp, Tyr, and Ile. Previous work has shown that dipeptides bearing either type 1 or type 2 N-terminal residues act as weak but specific inhibitors of the N-end rule pathway. We took advantage of the two-site architecture of Ubr1p to explore the feasibility of bivalent N-end rule inhibitors, whose expected higher efficacy would result from higher affinity of the cooperative (bivalent) binding to Ubr1p. The inhibitor comprised mixed tetramers of beta-galactosidase that bore both N-terminal Arg (type 1 residue) and N-terminal Leu (type 2 residue) but that were resistant to proteolysis in vivo. Expression of these constructs in S. cerevisiae inhibited the N-end rule pathway much more strongly than the expression of otherwise identical beta-galactosidase tetramers whose N-terminal residues were exclusively Arg or exclusively Leu. In addition to demonstrating spatial proximity between the type 1 and type 2 substrate-binding sites of Ubr1p, these results provide a route to high affinity inhibitors of the N-end rule pathway.

Additional Information

© 1999 by The American Society for Biochemistry and Molecular Biology, Inc. (Received for publication, February 9, 1999) We thank members of the Varshavsky laboratory, especially A. Kashina and G. Turner, for helpful discussions and advice in the course of this work. We also thank I. Davydov, F. Du, F. Navarro-Garcia, H. Rao, and especially G. Turner for comments on the manuscript. This work was supported by National Institutes of Health Grant DK39520 (to A. V.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Attached Files

Published - KWOjbc99.pdf

Files

KWOjbc99.pdf
Files (250.9 kB)
Name Size Download all
md5:a3c2a07606d8ed32172afa8b857397bb
250.9 kB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 16, 2023